Universe Pharmaceuticals Inc (UPC)

Universe Pharmaceuticals Inc. is a healthcare company listed on NASDAQ under the ticker UPC. Through its subsidiaries, the company is engaged in the production, marketing, distribution, and sale of traditional Chinese medicine-related products in China. Its portfolio includes treatments aimed at common chronic conditions affecting older adults, as well as medicines for cold and flu symptoms. The company also distributes third-party products such as biomedical drugs, medical devices, traditional Chinese medicine materials, and dietary supplements. Universe Pharmaceuticals serves pharmaceutical companies, hospitals, clinics, and drugstore chains. Founded in 1998, the company is headquartered in Ji'An, China, and is a subsidiary of Sununion Holding Group Limited.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-UPC
Not available
Not available
Not available
Weak
0.0%
January 29, 2027
0.4x
1.4x
24.419 M
4.197 M
28.6%
11.1%
10.0
638.1%
Valuation • Fair Value

Universe Pharmaceuticals Inc (NASDAQ-UPC) Fair Value by Valuation Model

No usable valuation estimate is currently available for Universe Pharmaceuticals Inc (NASDAQ-UPC); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Universe Pharmaceuticals Inc (NASDAQ-UPC). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Universe Pharmaceuticals Inc (NASDAQ-UPC)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

17.742 M

Current operating scale indicator.

Revenue Forecast

17.859 M

Forward revenue estimate.

EBITDA

-1.61 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Universe Pharmaceuticals Inc (NASDAQ-UPC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Universe Pharmaceuticals Inc (NASDAQ-UPC)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-1.24

Higher caution zone on this screen.

Altman Z-Score

10.0

Relatively strong balance-sheet zone.

FCF / Net Income

638.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Universe Pharmaceuticals Inc (NASDAQ-UPC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Universe Pharmaceuticals Inc (NASDAQ-UPC)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

January 29, 2027

Days to Earnings

133

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Universe Pharmaceuticals Inc (NASDAQ-UPC), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Universe Pharmaceuticals Inc (NASDAQ-UPC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Universe Pharmaceuticals Inc (NASDAQ-UPC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Universe Pharmaceuticals Inc (NASDAQ-UPC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Universe Pharmaceuticals Inc (NASDAQ-UPC) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Universe Pharmaceuticals Inc (NASDAQ-UPC) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Universe Pharmaceuticals Inc (NASDAQ-UPC) Stock FAQ

Data-supported answers about Universe Pharmaceuticals Inc (NASDAQ-UPC), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Weak
Current financial-health read

A reliable fair value estimate is not currently available for Universe Pharmaceuticals Inc (NASDAQ-UPC). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Universe Pharmaceuticals Inc (NASDAQ-UPC) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Universe Pharmaceuticals Inc (NASDAQ-UPC) is January 29, 2027.

The latest available data indicates no current dividend yield for Universe Pharmaceuticals Inc (NASDAQ-UPC).

The current market capitalization listed for Universe Pharmaceuticals Inc is 24.419 M.

The current enterprise value listed for Universe Pharmaceuticals Inc is 4.197 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Universe Pharmaceuticals Inc is NASDAQ-UPC, and the stock is listed on NASDAQ.

Universe Pharmaceuticals Inc (NASDAQ-UPC) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Universe Pharmaceuticals Inc is 28.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Universe Pharmaceuticals Inc is 11.1%. Free float helps investors understand how much of the share base is available for public trading.